Alpha Tau Medical Ltd.

US$13.72As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:DRTSHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR 6.46%
Div yield —
ROE (141.68%)
Biotechnology
Beta (5Y) 1.29
PE TTM —
TSR TTM 229.41%
Mkt cap US$1.267B
ROIC (39.61%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$14
4.92%
103.29%
Hold 3|7|9|11|4
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.24
0.26
0.27
0.26
3.22%
13.53%
17.82%
8.62%
Revenue$M
64.96
67.52
67.07
67.07
0.77%
6.75%
0.18%
0.68%
Peers (US$1.267B)
Cap (US$)
PE
546.1M
—
203.6M
—
Capital
TTM
5Y
10Y
Leveragex
0.981
0.064
0.043
EBIT/Intx
1.215
0.145
0.142
Own earn%
119.23
82.52
81.75
Sh yield%
39.21
27.35
24.90
Owners
Insiders/Inst%
4.95
74.24
Short interest%
0.73
SBC / revenue%
4.24
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
3–9
$1 testx
0.0
Incr. ROIC%
4